Sotto l'alto Patrocinio della
Presidenza del Consiglio dei Ministri

TUMORI a Journal of Clinical and Experimental Oncology
Volume 97 - Number 4, July-August 2011

Abstract

EPIDEMIOLOGY AND PREVENTION

• Stefano Ciatto, Daniela Bernardi, and Francesca Caumo
  Evidence of interval cancer proportional incidence and review from mammography screening programs in Italy
  Tumori 2011; 97: 419-422
• Irene Tramacere, Silvano Gallus, Roberta Pacifici, Piergiorgio Zuccaro, Paolo Colombo, and Carlo La Vecchia
  Smoking in young and adult population, Italy 2009
  Tumori 2011; 97: 423-427
• Elaine Yuen, Daniel Louis, Luca Cisbani, Carol Rabinowitz, Rossana De Palma, Vittorio Maio, Maurizio Leoni, and Roberto Grilli
  Using administrative data to identify and stage breast cancer cases: implications for assessing quality of care
  Tumori 2011; 97: 428-435

MEDICAL ONCOLOGY

• Tulio EF Pfiffer, Daniel Seehofer, Annett Nicolaou, Ruth Neuhaus, Hanno Riess, and Ralf U Trappe
  Recurrent hepatocellular carcinoma in liver transplant recipients: parameters affecting time to recurrence, treatment options and survival in the sorafenib era
  Tumori 2011; 97: 436-441
• Stefania Gori, Massimo Di Maio, Carmine Pinto, Oscar Alabiso, Editta Baldini, Enrico Barbato, Giordano Domenico Beretta, Stefano Bravi, Orazio Caffo, Luciano Canobbio, Francesco Carrozza, Saverio Cinieri, Giorgio Cruciani, Angelo Dinota, Vittorio Gebbia, Lucio Giustini, Claudio Graiff, Annamaria Molino, Antonio Muggiano, Giuliano Pandoli, Fabio Puglisi, Pierosandro Tagliaferri, Silverio Tomao, and Marco Venturini on behalf of AIOM Working Group "Interaction with Regional Sections" (2009-2011)
  Disparity in the "time to patient access" to new anticancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM)
  Tumori 2011; 97: 442-448
• Nicola Battelli, Alessandro Bittoni, Alessandra Pagliacci, Laura Zepponi, Mario Scartozzi, Carlo Mariotti, and Stefano Cascinu
  Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity
  Tumori 2011; 97: 449-453
• Elena Collovà, Federica Sebastiani, Elisabetta De Matteis, Daniele Generali, Gaetano Aurilio, Francesco Boccardo, Sergio Crispino, and Giorgio Cruciani
  Use of metronomic chemotherapy in oncology: results from a national Italian survey
  Tumori 2011; 97: 454-45
• Zafer Kocak, Mert Saynak, Kazim Uygun, Yener Yoruk, Alaattin Ozen, Necdet Sut, Gundeniz Altiay, Murat Caloglu, Altemur Karamustafaoglu, Ufuk Usta, Hakan Karagol, and Osman N Hatipoglu
  Trimodality treatment in patients with superior sulcus tumors: hopes and realities
  Tumori 2011; 97: 459-465
• Tingsong Yang, Xiaojun Shen, Xiaojun Tang, Guo Wei, Hao Zhang, Chenghui Du, Xuchao Xue, Liye Ma, Mingming Nie, and Jianwei Bi
  Phase II trial of oxaliplatin plus oral capecitabine as firstline chemotherapy for patients with advanced gastric cancer
  Tumori 2011; 97: 466-472
• Ozkan Kanat, Saadetin Kilickap, Taner Korkmaz, Bala Basak Ustaalioglu Oven, Mustafa Canhoroz, Erdem Cubukcu, Sahsine Tolunay, Turkkan Evrensel, and Osman Manavoglu
  Primary small cell carcinoma of the breast: report of seven cases and review of the literature
  Tumori 2011; 97: 473-478
• Athanasios Bantis, Athanasios Zissimopoulos, Petros Sountoulides, Christos Kalaitzis, Stelios Giannakopoulos, Savas Deftereos, Giorgos Tsakaldimis, Vasilios Thomaidis, and Stavros Touloupidis
  Bisphosphonateinduced osteonecrosis of the jaw in patients with bone metastatic, hormonesensitive prostate cancer. Risk factors and prevention strategies
  Tumori 2011; 97: 479-483

RADIATION ONCOLOGY

• Stephanie E Combs, Florian Sterzing, Matthias Uhl, Gregor Habl, Kai Schubert, Jürgen Debus, and Klaus Herfarth
  Helical tomotherapy for meningiomas of the skull base and in paraspinal regions with complex anatomy and/or multiple lesions
  Tumori 2011; 97: 484-491
• Francesco Ricchetti, Salvina Barra, Stefano Agostinelli, Stefano Vagge, Michela Marcenaro, and Renzo Corvò
  Feasibility of helical tomotherapy for radical dose retreatment in pelvic area: a report of 4 cases
  Tumori 2011; 97: 492-497
• Pierfrancesco Franco, Paola Catuzzo, Domenico Cante, Maria Rosa La Porta, Piera Sciacero, Giuseppe Girelli, Valeria Casanova Borca, Massimo Pasquino, Gianmauro Numico, Santi Tofani, Teodoro Meloni, Umberto Ricardi, and Franca Ozzello
  TomoDirect: an efficient means to deliver radiation at static angles with tomotherapy
  Tumori 2011; 97: 498-502
• Stefano Tomatis, Mauro Carrara, Elisa Massafra, Giovanni Naldi, Mauro Palazzi, Ester Orlandi, and Renato Marchesini
  Geometry of volumes in radiotherapy planning. A new method for a quantitative assessment
  Tumori 2011; 97: 503-509

PSYCOONCOLOGY

• Ivana Truccolo, Rosaria Bufalino, Maria Antonietta Annunziata, Anita Caruso, Anna Costantini, Gaetana Cognetti, Antonio Florita, Dina Pero, Patrizia Pugliese, Roberta Tancredi, and Francesco De Lorenzo
  National Cancer Information Service in Italy: an information points network as a new model for providing information for cancer patients
  Tumori 2011; 97: 510-516

DIAGNOSTIC PROCEDURES

• Bartlomiej Szynglarewicz, Piotr Kasprzak, Jan Kornafel, Jozef Forgacz, Marek Pudelko, Adam Majewski, and Rafal Matkowski
  Duration time of vacuumassisted biopsy for nonpalpable breast masses: comparison between stereotactic and ultrasoundguided procedure
  Tumori 2011; 97: 517-521

IMMUNOLOGY

• Shen Zhao, Jie-yu Li, Xiao-bin Zheng, Feng Peng, Yun-bin Ye, and Qiang Chen
  Irradiated haploidentical donor leukocyte infusions as an adoptive immunotherapy strategy to induce hostversustumor effects
  Tumori 2011; 97: 522-531

PROGNOSTIC FACTORS

• Sanda Jelisavac-Cosic, Maja Sirotkovic-Skerlev, Ana Kulic, Jasminka Jakic-Razumovic, Zdenko Kovac, and Damir Vrbanec
  Prognostic significance of urokinasetype plasminogen activator (uPA) and plasminogen activator inhibitor (PAI1) in patients with primary invasive ductal breast carcinoma - a 7.5year followup study
  Tumori 2011; 97: 532-539
• Zhi-Feng Wang, Qin-Jiang Liu, Shi-Qi Liao, Rong Yang, Ting Ge, Xin He, Cai-Ping Tian, and Wei Liu
  Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma
  Tumori 2011; 97: 540-546

ONLINE ONLY ARTICLES CASE REPORTS

• Ronggang Lang, Yu Fan, Xilin Fu, and Li Fu
  Metaplastic breast carcinoma with extensive osseous differentiation: a report of two cases and review of the literature
  Tumori 2011; 97: e1-e5
• Teo Zenico, Mauro Saccomanni, Umberto Salomone, and Eduard Bercovich
  Primary renal angiosarcoma: case report and review of world literature
  Tumori 2011; 97: e6-e9
• Anna Rossetto, Enrico Saccomano, Aron Zompicchiatti, Claudio Avellini, Silvia Toffoli, GianMaria Miolo, Sergio Frustaci, and Alessandro Uzzau
  Mesenchymal chondrosarcoma of the spleen: report of a case
  Tumori 2011; 97: e10-e15
• Milica Kontic, Ruza Stevic, Jelena Stojsic, Biljana Jekic, and Vera Bunjevacki
  Synchronous primary lung cancers: a multidisciplinary approach in diagnosis
  Tumori 2011; 97: e16-e19

Ultimo aggiornamento: giovedì 13 ottobre 2011

Le Riviste

• TUMORI a Journal of Clinical and Experimental Oncology

© Fondazione IRCCS Istituto Nazionale dei Tumori